SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the Global Central Venous Catheter Market is estimated to be valued at US$ 2,002.2 million in 2020 and is expected to exhibit a CAGR of ...

A systematic literature review showed that interventions to reduce unnecessary central venous catheter use can significantly decrease the rate of central-line-associated bloodstream infections, or ...

It has been known for decades that central lines that have blood clots have a double the risk of catheter sepsis. Reducing thrombosis risks is the answer.” — Greg Vigna, M.D., J.D. LOS ANGELES, CA, ...

Bluegrass Vascular picked up a CE mark for its central venous access catheter and is kicking off a limited commercial release for the device. The Surfacer Inside-Out Access Catheter System facilitates ...

Background: A significant decrease in catheter-related infections was demonstrated in our earlier randomized controlled trial of central venous catheter (CVC) care in hematologic patients. Objective: ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced that Teleflex and Arrow International LLC are recalling both the Arrow MAC Two-Lumen Central ...

The management of many medical and surgical conditions often involves long-term infusion of intravenous fluids, broad-spectrum antibiotics, chemotherapeutic agents for cancer, critical care therapies, ...

Central venous stenosis is a significant clinical challenge affecting haemodialysis patients. It is predominantly associated with previous central venous catheter placements and repeated vascular ...

Bone mineral density in childhood cancer survivors (CCS). Background: The aims of this prospective randomized study were two-fold: To estimate the incidence of overall venous thrombosis (VT) including ...

One of the main problems in interpreting the literature concerning infectious complications of CVCs is the inconsistent use of terms and definitions. Furthermore, it is often unclear exactly how the ...